We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Select Medical Agrees to Acquire Valir Rehabilitation Hospital
Read MoreHide Full Article
Select Medical Holdings Corporation (SEM - Free Report) recently inked an agreement to acquire Valir Rehabilitation Hospital from Valir Health. The hospital is a 50-bed inpatient rehabilitation facility located in Oklahoma City. The financial details of the deal were kept under wraps.
This move bodes well for Select Medical as it will expand its footprint in Oklahoma City. The buyout seems to be a time-opportune move on the part of Select Medical as this region is witnessing a growing demand for inpatient rehabilitative care.
SEM is currently present in Oklahoma City in the outpatient care market and post-ICU. However, with this acquisition, the company is foraying into inpatient care. SEM currently operates Select Specialty Hospital, a critical illness recovery hospital in the region, along with 29 Select Physical Therapy outpatient centers.
SEM’s hospital divisions have been contributing to its growth trajectory, especially its inpatient rehabilitation division. This unit generated double-digit revenue growth and adjusted EBITDA in the second quarter of 2024. This acquisition also reflects SEM’s efforts to grow its existing networks and improve its financial results as a by-product. SEM has been quite active in pursuing opportunistic acquisitions and identifying JVs. The company has many upcoming projects in the inpatient rehabilitation space and it expects this business to continue with its strong performance in 2024.
Expansion initiatives, similar to the latest one, are likely to boost SEM’s revenues from its rehabilitation hospitals, whose count was 33 as of June 30, 2024. The Rehabilitation Hospital segment accounted for nearly 15.2% of Select Medical’s overall top line in the second quarter.
SEM’s Zacks Rank and Price Performance
SEM currently carries a Zacks Rank #4 (Sell).
Shares of Select Medical have gained 28.4% in the past year compared with the industry’s 22.3% growth.
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks in the Medical space are HCA Healthcare, Inc. (HCA - Free Report) , LeMaitre Vascular, Inc. (LMAT - Free Report) , and The Ensign Group, Inc. (ENSG - Free Report) . While HCA Healthcare and LeMaitre Vascular currently sport a Zacks Rank #1 (Strong Buy), The Ensign Group carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
HCA Healthcare’s earnings surpassed the Zacks Consensus Estimate in three of the last four quarters and missed the mark once, the average surprise being 8.24%. The consensus estimate for HCA’s 2024 earnings indicates a rise of 18.4% from the year-ago number. The consensus mark for revenues indicates growth of 8.9% from the year-ago figure. The Zacks Consensus Estimate for HCA’s earnings has moved 1.7% north in the past 30 days.
LeMaitre Vascular’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 8.87%. The consensus estimate for LMAT’s 2024 earnings indicates an improvement of 37% from the year-ago figure. The consensus mark for revenues implies growth of 13% from the year-ago figure. The Zacks Consensus Estimate for LMAT’s earnings has moved 4.5% north in the past 30 days.
The Ensign Group’s earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 1.40%. The consensus estimate for ENSG’s 2024 earnings indicates a rise of 14.1% from the year-ago number. The consensus mark for revenues implies an improvement of 13.1% from the year-ago figure. The Zacks Consensus Estimate for ENSG’s earnings has moved 0.4% north in the past 30 days.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Select Medical Agrees to Acquire Valir Rehabilitation Hospital
Select Medical Holdings Corporation (SEM - Free Report) recently inked an agreement to acquire Valir Rehabilitation Hospital from Valir Health. The hospital is a 50-bed inpatient rehabilitation facility located in Oklahoma City. The financial details of the deal were kept under wraps.
This move bodes well for Select Medical as it will expand its footprint in Oklahoma City. The buyout seems to be a time-opportune move on the part of Select Medical as this region is witnessing a growing demand for inpatient rehabilitative care.
SEM is currently present in Oklahoma City in the outpatient care market and post-ICU. However, with this acquisition, the company is foraying into inpatient care. SEM currently operates Select Specialty Hospital, a critical illness recovery hospital in the region, along with 29 Select Physical Therapy outpatient centers.
SEM’s hospital divisions have been contributing to its growth trajectory, especially its inpatient rehabilitation division. This unit generated double-digit revenue growth and adjusted EBITDA in the second quarter of 2024. This acquisition also reflects SEM’s efforts to grow its existing networks and improve its financial results as a by-product. SEM has been quite active in pursuing opportunistic acquisitions and identifying JVs. The company has many upcoming projects in the inpatient rehabilitation space and it expects this business to continue with its strong performance in 2024.
Expansion initiatives, similar to the latest one, are likely to boost SEM’s revenues from its rehabilitation hospitals, whose count was 33 as of June 30, 2024. The Rehabilitation Hospital segment accounted for nearly 15.2% of Select Medical’s overall top line in the second quarter.
SEM’s Zacks Rank and Price Performance
SEM currently carries a Zacks Rank #4 (Sell).
Shares of Select Medical have gained 28.4% in the past year compared with the industry’s 22.3% growth.
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks in the Medical space are HCA Healthcare, Inc. (HCA - Free Report) , LeMaitre Vascular, Inc. (LMAT - Free Report) , and The Ensign Group, Inc. (ENSG - Free Report) . While HCA Healthcare and LeMaitre Vascular currently sport a Zacks Rank #1 (Strong Buy), The Ensign Group carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
HCA Healthcare’s earnings surpassed the Zacks Consensus Estimate in three of the last four quarters and missed the mark once, the average surprise being 8.24%. The consensus estimate for HCA’s 2024 earnings indicates a rise of 18.4% from the year-ago number. The consensus mark for revenues indicates growth of 8.9% from the year-ago figure. The Zacks Consensus Estimate for HCA’s earnings has moved 1.7% north in the past 30 days.
LeMaitre Vascular’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 8.87%. The consensus estimate for LMAT’s 2024 earnings indicates an improvement of 37% from the year-ago figure. The consensus mark for revenues implies growth of 13% from the year-ago figure. The Zacks Consensus Estimate for LMAT’s earnings has moved 4.5% north in the past 30 days.
The Ensign Group’s earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 1.40%. The consensus estimate for ENSG’s 2024 earnings indicates a rise of 14.1% from the year-ago number. The consensus mark for revenues implies an improvement of 13.1% from the year-ago figure. The Zacks Consensus Estimate for ENSG’s earnings has moved 0.4% north in the past 30 days.